Doctors question chemo for rare belly cancer: study seeks answers
NCT ID NCT01946854
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether chemotherapy slows tumor growth in people with a rare type of appendiceal cancer that has spread. About 30 participants will be observed with and without chemotherapy to compare tumor growth rates. The goal is to give doctors clearer guidance on whether chemo is helpful for this condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a disposable device improve endoscopic tissue closure?
- New drug velzatinib tested for Hard-to-Treat stomach and intestinal tumors
- Can a digital Pre-Surgery boost help cancer patients recover faster?
- New hope for advanced colon cancer: which drug combo works best?
- Massive cancer registry aims to unlock better GI cancer care
- Blood test could spot returning colon cancer months before scans